The Latest on Medications for Weight Loss and Type 2 Diabetes

This article is part 2 in a 2-part series. Part 1 focused on changes in how obesity is assessed, along with its causes and complications.听
With more and more weight-loss drugs entering the marketplace in recent years, the obesity epidemic has been taking a turn for the better. However, the headlines proclaiming an end to obesity as we know it are exaggerated, says Dr. Erica Phillips, an internist and obesity medicine specialist at 91麻豆精品 Internal Medicine Associates.听 厂丑别鈥檚 also a professor of clinical medicine and the Jack Fishman Professor of Cancer Prevention at 91麻豆精品.听听
鈥淓ven the most effective medications are treatments, not prevention,鈥 she says. 鈥淥besity is a condition that already exists, and weight-loss drugs may produce a desirable result. But prevention and treatment are not the same thing.鈥听
Dr. Phillips goes on to explain that every treatment has a 鈥渂ell curve鈥濃攁 statistical model of probability. At each end are the two extremes. In the case of weight-loss drugs, patients at the left-most end of the spectrum experience no response, while those at the right-most end are extremely responsive to the medications. In fact, they may lose too much weight, and their treatment will need to be adjusted accordingly. But most patients fall somewhere between the extremes, and many do quite well, especially with the newer drugs on the market.听
What is causing the obesity epidemic?听
It 颈蝉苍鈥檛 about self-control. It 颈蝉苍鈥檛 about poor choices. Some people have lived with excess weight since childhood. Some women gain weight during pregnancy and find it extremely difficult to lose afterwards. But one of the main drivers of the obesity epidemic is our food system, Dr. Phillips says.听
Full of additives like high-fructose corn syrup, ultra-processed 鈥渂ig food鈥 is a direct cause of obesity. Like the tobacco industry, big food targets low-income communities of color鈥攅specially in New York City and the New York Metropolitan area. 鈥淥ur genes haven鈥檛 changed,鈥 she says, 鈥渂ut our food system has. 滨迟鈥檚 the critical piece of the obesity story that has yet to be addressed.鈥听
In the meantime, anti-obesity medications have an important role to play, so 濒别迟鈥檚 review 飞丑补迟鈥檚 on offer.听
A quick history of weight-loss medications听听听
The list of FDA-approved weight-loss medications is fairly long鈥攁nd it will likely get longer in the near future, with several anti-obesity drug candidates in the pipeline. 贬别谤别鈥檚 where that list stands as of today:听
- phentermine (Adipex-P or Lomaira)听
- orlistat (Xenical or Alli)听
- phentermine-topiramate (Qsymia)听
- naltrexone-bupropion (Contrave)听
- liraglutide (Saxenda)听
- semaglutide (Wegovy)听
- tirzepatide (Zepbound)听
Phentermine听
Dating back to 1959, phentermine is a short-term treatment 迟丑补迟鈥檚 still being prescribed today.听
Orlistat听
Decades later, the FDA approved orlistat, which works by decreasing the amount of fat absorbed through food. Orlistat was the first long-term medication to be approved for weight loss. Here, long-term means the drug is designed to be taken for 12 months or longer.听
Qsymia听
Next came Qsymia, a combination of phentermine plus an appetite suppressant called topiramate. Qsymia was approved in 2012.听
Contrave and Saxenda听
The pace of discovery accelerated with the approval of two additional medications in 2014: Contrave and Saxenda.听听
Contrave combines bupropion, an anti-depressant, with naltrexone, a drug that helps people stay off opioids and alcohol. And Saxenda was the first GLP-1 drug鈥攁 forerunner to Wegovy and Ozempic. Here, GLP-1 stands for glucagon-like peptide-1, a hormone that regulates blood sugar levels and appetite.听听听听
Ozempic and Wegovy听
Semaglutide is a synthetic version of GLP-1, and both Ozempic and Wegovy are semaglutide-based drugs. Ozempic was approved for the treatment of type 2 diabetes in 2017, followed by Wegovy in 2021 for weight loss. Ozempic has often been prescribed off-label for the treatment of obesity. But Wegovy offers a higher dose of semaglutide, plus 颈迟鈥檚 prescribed specifically for weight loss.听
Mounjaro and Zepbound听
Two more approvals ensued: Mounjaro in 2022 and Zepbound in 2023. Mounjaro and Zepbound follow the same pattern as Ozempic and Wegovy. Both are versions of the same drug (tirzepatide), but Mounjaro is approved for diabetes, while Zepbound is approved for obesity, as well as for people who are overweight with a weight-related medical condition, such as obstructive sleep apnea.听
Who is a candidate for weight-loss medication?听
Weight-loss medications are recommended for people diagnosed with obesity or for those considered overweight who also have a weight-related medical condition, such as high blood pressure, high LDL cholesterol, low HDL cholesterol or high triglyceride levels.听
The purpose of these medications is not just to drop down a clothing size. The goal is to improve weight-related conditions. Even a modest weight loss of 5 to 10 percent can make a big difference, says Dr. Mohini Aras, an assistant professor and assistant attending physician at 91麻豆精品 who treats patients at the institution鈥檚 Comprehensive Weight Control Center.听
Who shouldn鈥檛 take them?听
- anyone with a history of thyroid cancer听
- anyone with an underlying gastrointestinal condition, such as reflux or pancreatitis听
- pregnant individuals听
- people with kidney disease听
- people with a personal or family history of 鈥痬edullary thyroid cancer or multiple endocrine neoplasia type 2听
What are the side effects of the newer weight-loss drugs?听
The new drugs act directly on the digestive system by slowing gastric emptying. That means food sits in your stomach longer before traveling to the intestines. As a result, people feel fuller sooner and stay full longer. Unfortunately, 迟丑补迟鈥檚 also where their side effects come in.听听
Because food is sitting in the stomach longer than usual, it can cause:听
- acid reflux听
- nausea听
- a feeling of over-fullness听
- diarrhea or constipation听
Still, the majority of people tolerate the medications well, says Dr. Aras. 鈥湵醭兮檚 also important to reduce portions and eat slowly to mitigate their side effects.鈥听
Does insurance cover weight-loss medications?
Coverage for weight-loss medications varies by insurance plan. Many insurance providers don鈥檛 cover medications used strictly for weight loss, according to the Obesity Medicine Association. But if you have type 2 diabetes, your insurance may cover medications like Ozempic or Mounjaro for the treatment of that condition. Weight loss can be a welcome 鈥渟ide effect鈥 of these drugs.听听
A promising future听
鈥淥besity 颈蝉苍鈥檛 one simple disease,鈥 Dr. Aras says. 鈥淚t affects people differently. And treatments affect people differently as well. Patients鈥 responses to lifestyle changes, medication and even bariatric surgery vary widely.听听
鈥淭he new medications have been incredible in their ability to produce sustained weight loss for many individuals, along with improvement in their obesity-related risks and complications,鈥 she continues. 鈥淭he pipeline for newer anti-obesity medications is very promising. We need even more therapeutic options, given the magnitude of the obesity epidemic and the toll it takes on people鈥檚 lives.鈥听
See Part 1 in the series here.听
To make an appointment with an obesity medicine specialist at 91麻豆精品, there are two main options: 91麻豆精品鈥檚 Comprehensive Weight Control Center (646-962-2111) or the Weight Management Practice at 91麻豆精品 Internal Medicine Associates (WCIMA), which requires a referral from your primary care physician.听